首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Integrative cancer therapies

缩写:INTEGR CANCER THER

ISSN:1534-7354

e-ISSN:1552-695X

IF/分区:2.8/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引1380
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Alina Grumt,Sophia Huchel,Christian Keinki et al. Alina Grumt et al.
Background: Cancer patients increasingly use YouTube for nutritional guidance, yet information quality varies substantially. Existing text-based assessment tools fail to capture audiovisual content characteristics. This s...
Ya-Dong Chen,Zi-Yan He,Wen-Jie Zhao et al. Ya-Dong Chen et al.
Background: Colorectal cancer is one of the most common and fatal cancers worldwide. Despite therapeutic advancements, patients with stage II and III colon cancer often experience recurrences and metastases, particularly ...
Henriette Meyer,Daniela A Koppold,Osaid Shaker et al. Henriette Meyer et al.
Introduction: Aromatase inhibitor-induced musculoskeletal symptoms (AIMSS) or aromatase inhibitor-induced arthralgia (AIA), common side effects of long-term adjuvant endocrine therapy for breast cancer patients, can signi...
Shefaa M Alzoubi,Moudi M Alasmari,Saman A Ahmad et al. Shefaa M Alzoubi et al.
Prangos ferulacea is a widely recognized and valuable medicinal herb known for its diverse biological characteristics. Our study was conducted to evaluate the anticancer and immunomodulatory effects of P. ferulacea. Ethyl acetate, methanol,...
Majid Kamali,Masoomeh Ataei Kachooei,Bahareh Aminnezhad et al. Majid Kamali et al.
Background: Emerging evidence suggests that the ketogenic diet (KD) may support cancer treatment by improving metabolic parameters and reducing treatment-related side effects. This review aimed to synthesize evidence from...
Dong-Hyeon Kim,Mi-Sun Park,Keon-Jun Lee et al. Dong-Hyeon Kim et al.
Background: Lung cancer is the leading cause of cancer-related mortality, with non-small cell lung cancer (NSCLC) accounting for 80% to 85% of cases. While surgery and chemotherapy are primary treatments, their side effec...
Yi-Yang Jiang,Bin-Bin Li,Qian Meng et al. Yi-Yang Jiang et al.
Non-small-cell lung cancer (NSCLC) research has focused on complementary and well-established treatments with clear mechanisms and less toxicity. Immune dysregulation is vital in NSCLC progression and metastasis. Ze-qi decoction (ZQD) exhib...
Graziella Marino,Alexios Thodas,Carmela Cristiano et al. Graziella Marino et al.
With increasing survival rates for breast cancer (BC)-91% at 5 years and 80% at 15 years post-diagnosis-there is growing recognition of the importance of addressing long-term patient well-being. Beyond standard medical treatments, factors s...